<!DOCTYPE html> <html ⚡ lang="es"> <head> <meta charset="utf-8"> <title>Hay dos medicamentos que podr&iacute;an atacar al COVID-19: Salud</title> <meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=5,minimal-ui"> <link rel="preconnect" href="https://static.eu.criteo.net"> <link rel="preconnect" href="https://static.criteo.net"> <link rel="preconnect" href="https://ajax.googleapis.com"> <link rel="preconnect" href="https://www.google.com"> <link rel="preconnect" href="https://www.googletagmanager.com"> <link rel="preconnect" href="https://cm.g.doubleclick.net"> <link rel="preconnect" href="https://adservice.google.com"> <link rel="preconnect" href="https://pagead2.googlesyndication.com"> <link rel="preconnect" href="https://fonts.googleapis.com"> <link rel="preconnect" href="https://use.fontawesome.com"> <link rel="canonical" href="https://www.unotv.com/noticias/portal/nacional/detalle/hay-dos-medicamentos-que-podrian-atacar-al-covid-19-salud-944523/"> <link rel="amphtml" href="https://www.unotv.com/noticias/portal/nacional/detalle/hay-dos-medicamentos-que-podrian-atacar-al-covid-19-salud-944523/"> <style amp-boilerplate>body{-webkit-animation:-amp-start 8s steps(1,end) 0s 1 normal both;-moz-animation:-amp-start 8s steps(1,end) 0s 1 normal both;-ms-animation:-amp-start 8s steps(1,end) 0s 1 normal both;animation:-amp-start 8s steps(1,end) 0s 1 normal both}@-webkit-keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}@-moz-keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}@-ms-keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}@-o-keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}@keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}</style> <noscript> <style amp-boilerplate>body{-webkit-animation:none;-moz-animation:none;-ms-animation:none;animation:none}</style> </noscript> <style amp-custom>
      /* CSS Compiled:2020-03-29T15:47:30.944Z */

﻿html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,b,u,i,center,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td,article,aside,canvas,details,embed,figure,figcaption,footer,header,hgroup,menu,nav,output,ruby,section,summary,time,mark,audio,video{margin:0;padding:0;border:0;font-size:100%;font:inherit;vertical-align:baseline}article,aside,details,figcaption,figure,footer,header,hgroup,menu,nav,section{display:block}body{line-height:1}ol,ul{list-style:none}blockquote,q{quotes:none}blockquote:before,blockquote:after,q:before,q:after{content:'';content:none}table{border-collapse:collapse;border-spacing:0}.tag{color:#333}.tag.default{color:#148665}.tag.investigaciones-especiales{color:#0075d2}.tag.opinion{color:#148665}.tag.nacional{color:#0075d2}.tag.internacional{color:#f93}.tag.estados{color:#80c557}.tag.entretenimiento{color:#d50597}.tag.deportes{color:#cf1d13}.tag.negocios{color:#11171e}.tag.tecnologia{color:#0075d2}.tag.todo-en-uno{color:#0075d2}body{font-family:'Merriweather', sans-serif;color:#555;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;font-size:16px;overflow-x:hidden}h1,h2,h3,h4,h5,h6,nav,span,.magazine-title{font-family:'Nunito', sans-serif}h1{font-size:2.3em;font-weight:700;line-height:1.1}@media (max-width: 999px){h1{font-size:1.8em}}h2{font-size:2.2em;line-height:1.2;font-weight:700}h3{font-size:1.6em;margin:20px 0}h4{font-size:1.3em;margin-bottom:10px;text-transform:uppercase}hr{margin:20px 0;display:block}.container{width:940px;margin:0 auto}@media (max-width: 999px){.container{width:500px}}@media (max-width: 520px){.container{width:100%;padding:0 10px}}.container>h1{margin:20px 0}a{color:inherit;transition:all 0.3s;text-decoration:none}a:focus{outline:1px dashed #df4a32}p,ul,ol,blockquote{line-height:1.6;font-family:'Merriweather', sans-serif;font-size:1em}ol,ul{list-style:none}*{box-sizing:border-box}.section-title h1{color:white;padding:14px 0;font-size:1.4em}body{padding-top:60px}@media (max-width: 520px){body{padding-top:50px}}header{position:fixed;top:0;width:100%;background:white;z-index:1998;border-bottom:1px solid #E0DEDE;font-family:'Nunito', sans-serif;font-weight:600}header .btn-menu{cursor:pointer;position:absolute;top:50%;bottom:auto;transform:translateY(-50%);left:0}header .nav-right{position:absolute;top:50%;bottom:auto;transform:translateY(-50%);right:0;line-height:22px}header .btn-live{color:red;cursor:pointer}header .container{position:relative;height:60px}header .container>a{position:absolute;left:50%;top:50%;bottom:auto;right:auto;transform:translateX(-50%) translateY(-50%)}header small{margin-left:5px;font-size:.7em;text-transform:uppercase;position:relative;top:-2px;letter-spacing:1px}@media (max-width: 520px){header amp-img{height:40px}header .container{height:50px}header .nav-right{right:10px}header .btn-menu{left:10px}}@media (max-width: 520px){header amp-img{height:30px}}amp-lightbox{z-index:2001}.lightbox{background:rgba(0,0,0,0.5);width:100%;height:100%;position:absolute;display:flex;align-items:center;justify-content:center}.form-boletin{background:#F2F3F4;box-shadow:0 5px 10px rgba(0,0,0,0.09);border-radius:5px;overflow:hidden;padding:20px 40px 40px 40px}.form-boletin h2{font-size:2em}.form-boletin label{margin-top:20px;display:block}.form-boletin input[type="text"]{display:block;padding:8px 10px;border:1px solid #CCC;border-radius:5px;background:rgba(255,255,255,0.7);outline:none;width:100%;font-size:.9em;margin-top:20px}.form-boletin button{padding:8px 10px;border:none;border-radius:5px;background:#0075d2;outline:none;display:inline-block;color:white;font-size:.8em;letter-spacing:1px;margin-top:20px;text-transform:uppercase}.form-boletin button.secondary{background:transparent;color:#cf1d13}.form-boletin button i{margin-left:5px}#progressIndicator{position:fixed;width:100%;height:3px;top:0;transform:translateX(-100%);background-color:#f93;z-index:2000}amp-sidebar{background-color:white}amp-sidebar .block-search{background:#F2F3F4;padding:13px 30px}amp-sidebar .block-search fieldset{padding:0 10px;border:1px solid #CCC;border-radius:5px;background:rgba(255,255,255,0.7)}amp-sidebar .block-search input{background:transparent;border:none;outline:none;display:inline-block;width:87%;padding:8px 0;font-size:.9em}amp-sidebar .block-search button{background:transparent;border:none;outline:none;width:10%;display:inline-block;text-align:right;padding:8px 0}amp-sidebar .block-menu{border-bottom:1px solid #CCC;padding:30px 30px}amp-sidebar .block-menu li a{padding-top:5px;padding-bottom:5px;display:block}amp-sidebar .block-menu h4{font-weight:700;padding-bottom:10px}amp-sidebar amp-list{width:300px;font-size:0.9em}.banner{background:#EEE;padding:6.66667px 0;text-align:center}.article-list .banner{background:#FFF}.item-banner{width:300px;height:250px;margin:20px 0}@media (max-width: 999px){.item-banner{width:300px;height:auto;margin:0 auto 20px auto}}.item-banner-empty{width:300px;height:1px;margin:20px 0}.banner .only-desktop{display:block;margin:0 auto}@media (max-width: 999px){.banner .only-desktop{display:none}}.banner .only-mobile{display:none}@media (max-width: 999px){.banner .only-mobile{display:block;margin:0 auto}}.module-news{border-bottom:1px solid #E0DEDE}.module-news:nth-child(even){background:#fafbfc}.module-news:nth-child(even) .item-principal{flex-direction:row}.module-news:nth-child(odd){background:#f2f5f7}.module-news:nth-child(odd) .item-principal{flex-direction:row-reverse}.module-news.dark-gray{background:#333}.module-news.dark-gray h3,.module-news.dark-gray .magazine-title{color:white}.module-news .container{display:flex;flex-wrap:wrap;justify-content:space-between}.module-news .container>h1,.module-news .container h3,.module-news .container .magazine-title{width:100%;margin:20px 0;letter-spacing:1px;font-weight:900;display:flex;justify-content:space-between;align-items:baseline;font-size:1.6em}@media (max-width: 520px){.module-news .container>h1,.module-news .container h3,.module-news .container .magazine-title{font-size:1.3em}}.module-news .container>h1 small,.module-news .container h3 small,.module-news .container .magazine-title small{font-size:.5em;min-width:100px;text-align:right}.item-principal{width:100%;position:relative;display:flex;justify-content:space-between;border-radius:5px;overflow:hidden;box-shadow:0 5px 10px rgba(0,0,0,0.09)}@media (max-width: 999px){.item-principal{display:block}}.item-principal .thumbnail{width:620px}@media (max-width: 999px){.item-principal .thumbnail{width:100%}}.item-principal .content{width:320px;text-align:left;padding:20px;background:white}@media (max-width: 999px){.item-principal .content{width:100%}}@media (max-width: 520px){.item-principal .content{padding:10px}}.item-principal .content h2,.item-principal .content h1{font-size:1.8em}@media (max-width: 999px){.item-principal .content h2,.item-principal .content h1{font-size:1.6em}}@media (max-width: 520px){.item-principal .content h2,.item-principal .content h1{font-size:1.3em}}.item-principal .content .tag{padding:0 0 10px 0;display:block}.item-principal .content p{margin-top:10px}@media (max-width: 999px){.item-principal .content p{display:none}}.item-secondary{display:block;width:300px;margin:20px 0;box-shadow:0 5px 10px rgba(0,0,0,0.09);border-radius:5px;overflow:hidden;background:white}@media (max-width: 999px){.item-secondary{width:calc(50% - 10px)}.item-secondary .thumbnail .overlay i{font-size:2em}}.item-secondary h2{font-size:1.1em}.item-secondary .content{padding:20px;background:white}@media (max-width: 520px){.item-secondary .content{padding:10px}}.item-principal .tag,.item-secondary .tag{font-size:.8em;text-transform:uppercase;padding:6.66667px 0 10px 0;display:block;font-weight:700}.item-principal .thumbnail,.item-secondary .thumbnail{position:relative}.item-principal .overlay,.item-secondary .overlay{position:absolute;top:0;left:0;background:rgba(0,0,0,0.3);color:white;width:100%;height:100%;z-index:6}.item-principal .overlay i,.item-secondary .overlay i{position:absolute;left:50%;top:50%;bottom:auto;right:auto;transform:translateX(-50%) translateY(-50%);font-size:3em;text-shadow:0 0 15px rgba(1,0,0,0.3)}.module-news{padding:20px 0 30px 0}.module-news amp-carousel .item-history{width:200px;position:relative;display:block}.module-news amp-carousel .item-history amp-img{border-radius:6.66667px}.module-news amp-carousel .item-history .content{position:absolute;border-radius:6.66667px;top:0;left:0;background:rgba(0,0,0,0.3);color:white;width:100%;height:100%;z-index:6}.module-news amp-carousel .item-history .content h2{font-size:1.1em;white-space:normal;position:absolute;bottom:0;padding:10px}.module-news.more-news{padding-bottom:40px}.module-news.more-news .container .magazine-title{margin-bottom:0}.article-title{padding:40px 0}.article-title h1{text-align:center}@media (max-width: 999px){.article-title{padding:20px 0 10px 0}}.panel-principal-media amp-iframe,.panel-principal-media amp-youtube,.panel-principal-media amp-jwplayer{margin-bottom:20px}.section-article article{display:flex;flex-wrap:wrap;align-items:stretch}.panel-meta{width:150px;margin-right:20px}.panel-meta .the-meta{position:sticky;top:70px;font-size:0.8em;text-align:center;line-height:1.5}.panel-meta .the-meta .info span{display:block;text-transform:capitalize}.panel-meta .the-meta .info span.author{border-top:1px solid #CCC;border-bottom:1px solid #CCC;padding:10px 0}.panel-meta .the-meta p:last-of-type{border-top:1px solid #CCC;border-bottom:1px solid #CCC;padding:10px 0;margin:10px 0}@media (max-width: 999px){.panel-meta{width:100%;margin-right:0}.panel-meta .the-meta{position:static;padding:0;border:none;display:block}.panel-meta .the-meta .info span{display:inline-block;margin-right:5px}.panel-meta .the-meta .info span::after{content:'|';margin-left:5px}.panel-meta .the-meta .info span:last-of-type::after{content:''}.panel-meta .the-meta .info{margin:0 0 10px 0}.panel-meta .the-meta p:last-of-type{padding:0;margin:0;border:none}}.share{color:white}.share .amp-social-share{width:150px;height:35px;display:block;border-radius:100px;margin-bottom:20px;padding:10px;text-align:left;text-transform:uppercase;font-weight:700;background-size:26px;background-position-x:6px;text-align:center}.share .amp-social-share.btn-fbmessenger{background-color:#32529f;background-image:url("data:image/svg+xml;base64,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");background-size:18px;display:none}.share .amp-social-share span{margin:0;display:inline}.share .amp-social-share i{margin:0 10px}@media (max-width: 999px){.share{display:none}}#shareSticky.share{display:none;position:sticky;width:100%;text-align:center;padding:10px;z-index:9;background:white}@media (max-width: 999px){#shareSticky.share{display:block;top:60px}}@media (max-width: 520px){#shareSticky.share{top:50px}}#shareSticky.share .amp-social-share{width:38px;display:inline-block;margin-bottom:0}#shareSticky.share .amp-social-share.btn-fbmessenger{background-position:center}.item-galeria p{font-size:.9em;margin:10px 0}.item-galeria p i{margin-right:5px}.panel-content{width:calc(100% - 170px)}@media (max-width: 999px){.panel-content{width:100%}}.panel-image-meta{padding:10px 0;border-bottom:1px solid #CCC;margin-bottom:10px;font-size:.9em}.panel-image-meta i{margin-right:6.66667px}#ooyalaplayer{margin-bottom:20px}.panel-article p,.panel-article ul,.panel-article ol{margin-bottom:20px}.panel-article table{margin:20px 0}.panel-article table td{padding:10px 15px 10px 0}.panel-article table.lista td:before{content:"• "}.panel-article ul,.panel-article ol{margin-left:40px}.panel-article ul{list-style-type:disc}.panel-article ol{list-style-type:decimal}.panel-article a{color:#006ab8}.panel-article a:hover{text-decoration:underline}.panel-article em{font-style:italic}.panel-article strong{font-weight:700;color:#333}.panel-article>div{line-height:1.6}.panel-article h2{font-size:1.7em;margin-bottom:20px}.panel-article h3{font-size:1.4em;margin-bottom:20px}.panel-article .banner{margin-bottom:20px;background:none}.panel-article blockquote,.panel-article strong>em,.panel-article em>strong{font-style:normal;font-weight:400;display:block;background:#f9f9f9;border-left:10px solid #ccc;margin:1.5em 10px;padding:0.5em 10px;quotes:"“" "”" "‘" "’"}.panel-article blockquote:before,.panel-article strong>em:before,.panel-article em>strong:before{color:#ccc;content:open-quote;font-size:5em;line-height:0.1em;margin-right:0.15em;vertical-align:-0.4em;font-family:'Georgia', serif}.panel-article blockquote p,.panel-article strong>em p,.panel-article em>strong p{display:inline}.panel-article blockquote u,.panel-article strong>em u,.panel-article em>strong u{text-decoration:none;font-weight:600}.panel-article .giphy{width:80%;height:auto;margin:20px auto 10px auto;display:block}.panel-article .giphy+span{display:block;text-align:center;font-size:0.9rem;margin-bottom:20px}.panel-article .giphy+span a{font-weight:bold;color:#222}.content-article{padding:0 40px}.content-article h1{padding:40px 0}.content-article h2{margin-bottom:20px;font-size:1.3em}.content-article p,.content-article ul,.content-article ol{margin-bottom:20px}.content-article a{color:#006ab8}.content-article a:hover{text-decoration:underline}.content-article em{font-style:italic}.content-article strong{font-weight:700;color:#333}.panel-video-full .container{max-width:900px;padding-top:20px}.panel-video-full .share{display:flex;justify-content:center}.panel-video-full .share a{margin:20px 10px}.panel-video-full .panel-article{display:flex;padding:0}.panel-video-full .panel-article>div{width:50%;padding:20px}.gallery,.infographic{padding-bottom:20px}.gallery .item-gallery p,.infographic .item-gallery p{padding:10px}.gallery .item-gallery p u,.infographic .item-gallery p u{display:block;text-decoration:none;font-size:0.8em;color:#666}.gallery .item-gallery:last-of-type p,.infographic .item-gallery:last-of-type p{padding-bottom:0;margin-bottom:0}.item{width:100%;margin-bottom:20px;display:flex;border:1px solid #EEE;box-shadow:0px 3px 5px rgba(0,0,0,0.1);font-size:0.9em;color:#555}.item .thumb{position:relative;overflow:hidden;width:130px}.item .thumb i{display:block;width:50px;height:50px;line-height:50px;position:absolute;left:50%;top:50%;bottom:auto;right:auto;transform:translateX(-50%) translateY(-50%);position:absolute;text-align:center;border-radius:100px;font-size:1.8em;transition:all, 0.2s;z-index:99;color:white;text-shadow:1px 1px 4px rgba(0,0,0,0.4)}.item .item-content{padding:13.33333px;width:calc(100% - 130px)}.item .item-content h2{font-size:1em;line-height:1.2;color:#555;margin-bottom:0}.panel-article .panel-related a:hover{text-decoration:none}.panel-related{display:flex;justify-content:space-between;padding:10px 0;flex-wrap:wrap}.panel-related .banner{width:100%}.social-container{max-width:500px;margin:0 auto}@media (max-width: 999px){.social-container{max-width:100%}}.live-info{display:flex;justify-content:space-between;padding:10px 0}@media (max-width: 999px){.live-info{display:block}}.module-covid .updated{text-align:center;font-size:0.8em;width:100%}.module-covid .the-container{padding:0 20px}@media (max-width: 999px){.module-covid .the-container{padding:0}}.module-covid .container,.module-covid .the-container{display:flex;justify-content:space-between}.module-covid .container>div,.module-covid .the-container>div{width:30%;box-shadow:0 0 24px 0 rgba(0,0,0,0.06),0 1px 0 0 rgba(0,0,0,0.02);padding:10px;margin:20px 0}@media (max-width: 999px){.module-covid .container>div,.module-covid .the-container>div{width:33.33%}}.module-covid .container>div span,.module-covid .the-container>div span{display:block}.module-covid .container>div .cat,.module-covid .the-container>div .cat{color:white;border-radius:3px;padding:5px 10px;font-weight:bold;display:inline-block;margin-bottom:10px}@media (max-width: 999px){.module-covid .container>div .cat,.module-covid .the-container>div .cat{font-size:.8em}}.module-covid .container>div .blue,.module-covid .the-container>div .blue{background:#04bcd4}.module-covid .container>div .green,.module-covid .the-container>div .green{background:#20cab8}.module-covid .container>div .red,.module-covid .the-container>div .red{background:#f93b7a}.module-covid .container>div .number,.module-covid .the-container>div .number{font-size:2em;margin-bottom:10px}.module-covid .container>div .label,.module-covid .the-container>div .label{font-size:.9em}.module-covid-estados p{border-top:1px solid #EEE;font-size:.8em;text-align:center;padding-top:10px}.module-covid-estados .row{display:flex;flex-wrap:nowrap;margin-bottom:10px;align-items:center}.module-covid-estados .row:nth-child(7n+0) .valor .bar{background:#52a4fc}.module-covid-estados .row:nth-child(7n+1) .valor .bar{background:#80e051}.module-covid-estados .row:nth-child(7n+2) .valor .bar{background:#6e838e}.module-covid-estados .row:nth-child(7n+3) .valor .bar{background:#ef497c}.module-covid-estados .row:nth-child(7n+4) .valor .bar{background:#ffa840}.module-covid-estados .row:nth-child(7n+5) .valor .bar{background:#73bfb6}.module-covid-estados .row:nth-child(7n+6) .valor .bar{background:#8b7dc3}.module-covid-estados .row .estado{font-family:'Nunito', sans-serif;width:40%;text-align:right;padding-right:20px}.module-covid-estados .row .valor{width:70%;text-align:center;font-family:.8em;font-weight:bold}.module-covid-estados .row .valor .bar{box-sizing:content-box;padding:5px;color:white}.panel-results .item{flex-wrap:nowrap;line-height:1.2;align-items:center}.panel-results .item .content{width:80%}.panel-results .item .thumbnail{width:36%;max-width:100px;margin-right:10px}.panel-results .item .thumbnail i{display:none}footer{background:#11171e;color:rgba(255,255,255,0.8)}footer p{font-family:'Nunito', sans-serif}footer .container{display:flex;justify-content:space-between;padding:10px 0}footer .container:first-of-type{border-bottom:2px solid rgba(255,255,255,0.2)}footer .panel-follow-social{font-size:1.3em}footer .panel-follow-social .facebook{color:#39579a}footer .panel-follow-social .twitter{color:#50abef}footer .panel-follow-social .plus{color:#df4a32}footer .panel-follow-social .youtube{color:#cf1d13}footer .panel-follow-social .instagram{color:#3d719d}footer ul{display:flex;text-transform:uppercase;width:100%;font-family:'Nunito', sans-serif}footer ul a{display:block;padding:20px}@media (max-width: 999px){footer{text-align:center}footer ul{justify-content:center}footer .container{display:block}footer .panel-legales{font-size:.8em}}

      body {}
    </style> <script async src="https://cdn.ampproject.org/v0.js"></script> <script async custom-element="amp-animation" src="https://cdn.ampproject.org/v0/amp-animation-0.1.js"></script> <script async custom-element="amp-position-observer" src="https://cdn.ampproject.org/v0/amp-position-observer-0.1.js"></script> <script async custom-element="amp-list" src="https://cdn.ampproject.org/v0/amp-list-0.1.js"></script> <script async custom-element="amp-ad" src="https://cdn.ampproject.org/v0/amp-ad-0.1.js"></script> <script async custom-element="amp-analytics" src="https://cdn.ampproject.org/v0/amp-analytics-0.1.js"></script> <script async custom-template="amp-mustache" src="https://cdn.ampproject.org/v0/amp-mustache-0.2.js"></script> <script async custom-element="amp-sidebar" src="https://cdn.ampproject.org/v0/amp-sidebar-0.1.js"></script> <script async custom-element="amp-bind" src="https://cdn.ampproject.org/v0/amp-bind-0.1.js"></script> <script async custom-element="amp-form" src="https://cdn.ampproject.org/v0/amp-form-0.1.js"></script> <script async custom-element="amp-sticky-ad" src="https://cdn.ampproject.org/v0/amp-sticky-ad-1.0.js"></script> <script async custom-element="amp-lightbox" src="https://cdn.ampproject.org/v0/amp-lightbox-0.1.js"></script> <script async custom-element="amp-iframe" src="https://cdn.ampproject.org/v0/amp-iframe-0.1.js"></script> <script async custom-element="amp-social-share" src="https://cdn.ampproject.org/v0/amp-social-share-0.1.js"></script> <script async custom-element="amp-facebook-comments" src="https://cdn.ampproject.org/v0/amp-facebook-comments-0.1.js"></script> <link href="https://fonts.googleapis.com/css?family=Nunito:400,700,900|Merriweather:400,700" rel="stylesheet"> <link href="https://use.fontawesome.com/releases/v5.8.1/css/all.css" rel="stylesheet" integrity="sha384-50oBUHEmvpQ+1lW4y57PTFmhCaXp0ML5d60M1M7uH2+nqUivzIebhndOJK28anvf" crossorigin="anonymous"> <link rel="icon" href="favicon.ico" type="image/x-icon"> <link rel="shortcut icon" href="favicon.ico" type="image/x-icon"> <link rel="apple-touch-icon" sizes="57x57" href="/assets/img/favicon/apple-icon-57x57.png"> <link rel="apple-touch-icon" sizes="60x60" href="/assets/img/favicon/apple-icon-60x60.png"> <link rel="apple-touch-icon" sizes="72x72" href="/assets/img/favicon/apple-icon-72x72.png"> <link rel="apple-touch-icon" sizes="76x76" href="/assets/img/favicon/apple-icon-76x76.png"> <link rel="apple-touch-icon" sizes="114x114" href="/assets/img/favicon/apple-icon-114x114.png"> <link rel="apple-touch-icon" sizes="120x120" href="/assets/img/favicon/apple-icon-120x120.png"> <link rel="apple-touch-icon" sizes="144x144" href="/assets/img/favicon/apple-icon-144x144.png"> <link rel="apple-touch-icon" sizes="152x152" href="/assets/img/favicon/apple-icon-152x152.png"> <link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicon/apple-icon-180x180.png"> <link rel="icon" type="image/png" sizes="192x192" href="/assets/img/favicon/android-icon-192x192.png"> <link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicon/favicon-32x32.png"> <link rel="icon" type="image/png" sizes="96x96" href="/assets/img/favicon/favicon-96x96.png"> <link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicon/favicon-16x16.png"> <link rel="manifest" href="/manifest.json"> <meta name="description" content="Se trata de la hidroxicloroquina, actualmente utilizada para el paludismo o malaria y otro que ha sido utilizado para el coronavirus SARS, denominado remdesivir."> <meta name="keywords" content="Hay dos medicamentos que podr&iacute;an atacar al COVID-19: Salud"> <meta property="og:type" content="website"> <meta property="og:image" content="https://www.unotv.com/portal/unotv/imagenes/217658-Principal.jpg"> <meta property="og:image:width" content="1200"> <meta property="og:image:height" content="628"> <meta property="og:locale" content="es_MX"> <meta property="og:url" content="https://www.unotv.com/noticias/portal/nacional/detalle/hay-dos-medicamentos-que-podrian-atacar-al-covid-19-salud-944523/"> <meta property="og:title" content="Hay dos medicamentos que podr&iacute;an atacar al COVID-19: Salud"> <meta property="og:description" content="Se trata de la hidroxicloroquina, actualmente utilizada para el paludismo o malaria y otro que ha sido utilizado para el coronavirus SARS, denominado remdesivir."> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:site" content="@UnoNoticias"> <meta name="twitter:creator" content="@UnoNoticias"> <meta name="twitter:title" content="Hay dos medicamentos que podr&iacute;an atacar al COVID-19: Salud"> <meta name="twitter:description" content="Se trata de la hidroxicloroquina, actualmente utilizada para el paludismo o malaria y otro que ha sido utilizado para el coronavirus SARS, denominado remdesivir."> <meta name="twitter:image:src" content="https://www.unotv.com/portal/unotv/imagenes/217658-Principal.jpg"> <meta property="fb:admins" content="1296422395"> <meta property="fb:app_id" content="421619531304987"> <meta property="fb:pages" content="148786388488561"> <meta property="article:modified_time" content="2020-03-29T21:56:45-06:00"> <meta property="article:published_time" content="2020-03-03T00:49:50-06:00"> <meta property="article:publisher" content="148786388488561"> <meta property="article:tag" content="Hay dos medicamentos que podr&iacute;an atacar al COVID-19: Salud"> <meta property="al:ios:app_store_id" content="635790561"> <meta property="al:ios:app_name" content="UNOTV"> <meta property="al:android:package" content="com.telcel.apps.unotv"> <meta property="al:android:app_name" content="UnoTV"> <meta name="nota_id" content="82b94d57-1bab-4fb2-b155-ed9811b6b98a"> <meta name="nota_friendly_url" content="hay-dos-medicamentos-que-podrian-atacar-al-covid-19-salud-944523"> <meta name="nota_published_time" content="2020-03-03T00:49:50-06:00"> <meta name="nota_modified_time" content="2020-03-29T21:56:45-06:00"> <meta name="nota_tipo" content="video"> <meta name="nota_img" content="https://www.unotv.com/portal/unotv/imagenes/217658-Principal.jpg"> <meta name="nota_tipo_seccion" content="Noticias"> <meta name="nota_seccion" content="Noticias"> <meta name="nota_categoria" content="Nacional"> <meta name="nota_titulo" content="Hay dos medicamentos que podr&iacute;an atacar al COVID-19: Salud"> <meta name="nota_tags" content="Hay dos medicamentos que podr&iacute;an atacar al COVID-19: Salud"> <script type="application/ld+json">
    {
      	"@context": "https://schema.org",
      	"@type": "NewsArticle",
      	"mainEntityOfPage": {
      		"@type": "WebPage",
      		"@id": "https://www.unotv.com/noticias/portal/nacional/detalle/hay-dos-medicamentos-que-podrian-atacar-al-covid-19-salud-944523/"
      	},
      	"headline": "Hay dos medicamentos que podr\u00EDan atacar al COVID-19: Salud",
      	"image": "https://www.unotv.com/portal/unotv/imagenes/217658-Principal.jpg",
      	"datePublished": "2020-03-03T00:49:50-0600",
      	"dateModified": "2020-03-29T21:56:45-0600",
      	"author": {
      		"@type": "Person",
      		"name": "Ivan Perez"
      	},
      	"publisher": {
      		"@type": "Organization",
      		"name": "Uno TV",
      		"logo": {
      			"@type": "ImageObject",
      			"url": "https://www.unotv.com/assets/img/logo-unotv-amp.png",
      			"width": "600",
      			"height": "145"
      		}
      	},
      	"articleSection": "Nacional",
      	"description": "Se trata de la hidroxicloroquina, actualmente utilizada para el paludismo o malaria y otro que ha sido utilizado para el coronavirus SARS, denominado remdesivir.",
      	"keywords": "Hay dos medicamentos que podr\u00EDan atacar al COVID-19: Salud"
      }
    </script> </head> <body> <amp-iframe width="auto" layout="fixed-height" title="User Sync" height="1" sandbox="allow-scripts allow-same-origin" frameborder="0" src="https://ads.us.e-planning.net/uspd/1/?du=https%3A%2F%2Fads.us.e-planning.net%2Fgetuid%2F1%2F5a1ad71d2d53a0f5%3Fhttps%3A%2F%2Fib.adnxs.com%2Fprebid%2Fsetuid%3Fbidder%3Deplanning%26gdpr%3D0%26gdpr_consent%3D%26uid%3D%24UID"><amp-img layout="fill" src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" placeholder></amp-img></amp-iframe> <amp-analytics config="https://www.googletagmanager.com/amp.json?id=GTM-T25D5DX&amp;gtm.url=SOURCE_URL" data-credentials="include"></amp-analytics> <amp-analytics type="krux" config="https://cdn.krxd.net/controltag/amp/rqwp8pfzl.json"></amp-analytics> <div id="progressIndicator"></div> <amp-animation id="pogressAnimation" layout="nodisplay"> <script type="application/json">{"duration":"1s","fill":"both","iterations":"1","direction":"alternate","animations":[{"selector":"#progressIndicator","keyframes":[{"transform":"translateX(0)"}]}]}</script> </amp-animation> <amp-position-observer intersection-ratios="0" viewport-margins="100vh" on="scroll:pogressAnimation.seekTo(percent=event.percent)" layout="nodisplay"></amp-position-observer> <header role="banner"> <div class="container"> <div class="nav-left"><a class="btn-menu" on="tap:sidebar.toggle"><i class="fas fa-bars"></i><small>Men&uacute;</small></a></div><a href="/" aria-label="UnoTV.com"> <amp-img src="/assets/img/logo-unotv.svg" width="250" height="50" layout="intrinsic" alt="UnoTV.com"></amp-img></a> <amp-list reset-on-refresh="always" class="nav-right" items="live" height="22" width="85" layout="fixed" src="/json/live.json"> <template type="amp-mustache"> {{#titulo}} <a class="btn-live" href="{{url}}"> <i class="fab fa-youtube"></i> <small>En vivo</small> </a> {{/titulo}} </template> </amp-list> </div> </header> <amp-sidebar id="sidebar" side="left" layout="nodisplay"> <form class="block-search" method="GET" action="/buscador/" target="_top"> <fieldset> <input name="q" type="search" placeholder="Buscar"> <button type="submit"> <i class="fas fa-search"></i></button> </fieldset> </form> <amp-list reset-on-refresh="always" items="menu_unotv" height="950" layout="fixed-height" src="/assets/json/menu.json"> <template type="amp-mustache"> <div class="block-menu"> <h4><a href="{{url}}">{{descripcion}}</a></h4> <ul>{{#submenu}} <li> <a href="{{url}}">{{descripcion}}</a></li>{{/submenu}} </ul> </div> </template> </amp-list> </amp-sidebar> <div class="banner"> <amp-ad rtc-config='{"urls":["https://cdn.krxd.net/userdata/v2/amp/68975038-df03-48c2-b339-e58be1b85a15?segments_key=ksg&kuid_key=kuid", "https://ads.us.e-planning.net/hb/1/1d821/ADCID/HB_AMP/ROS?dc=1&e=ATTR(width)xATTR(height)!ATTR(data-slot)&ur=HREF"],"vendors":{"prebidappnexus":{"PLACEMENT_ID":"17112489"}},"timeoutMillis":750}' media="(min-width: 800px)" width="728" height="90" layout="fixed" type="doubleclick" data-slot="/121173452/UnoTV/noticias/nacional/LB01"></amp-ad> <amp-ad rtc-config='{"urls":["https://cdn.krxd.net/userdata/v2/amp/68975038-df03-48c2-b339-e58be1b85a15?segments_key=ksg&kuid_key=kuid", "https://ads.us.e-planning.net/hb/1/1d821/ADCID/HB_AMP/ROS?dc=1&e=ATTR(width)xATTR(height)!ATTR(data-slot)&ur=HREF"],"vendors":{"prebidappnexus":{"PLACEMENT_ID":"17112489"}},"timeoutMillis":750}' media="(max-width: 800px)" width="320" height="100" layout="fixed" type="doubleclick" data-slot="/121173452/UnoTV/noticias/nacional/LB01"></amp-ad> </div> <main role="main"> <div class="container"> <section class="section-article"> <div class="article-title"> <h1>Hay dos medicamentos que podr&iacute;an atacar al COVID-19: Salud</h1> </div> <article> <div class="panel-meta"> <div class="the-meta"> <div class="info"> <p><span>mar 03, 2020</span><span>00:49</span><span>Agencia</span></p> <p><span>Notimex</span><span>M&eacute;xico</span></p> </div> <div class="share"> <amp-social-share class="amp-social-share" width="auto" height="40" type="facebook" data-param-app_id="421619531304987"><span>compartir</span></amp-social-share> <amp-social-share class="amp-social-share" width="auto" height="40" type="twitter"><span>tuitear</span></amp-social-share> <amp-social-share class="amp-social-share btn-whatsapp" width="auto" height="40" type="whatsapp" data-share-endpoint="whatsapp://send" data-param-text="https://www.unotv.com/noticias/portal/nacional/detalle/hay-dos-medicamentos-que-podrian-atacar-al-covid-19-salud-944523/"><span>compartir</span></amp-social-share> <amp-social-share class="amp-social-share btn-email" width="auto" height="35" type="email" data-param-subject="Mira esta noticia en UnoTV.com"><span>enviar</span></amp-social-share> </div> </div> </div> <div class="share" id="shareSticky"> <amp-social-share class="amp-social-share" width="auto" height="35" type="facebook" data-param-app_id="421619531304987"></amp-social-share> <amp-social-share class="amp-social-share" width="auto" height="35" type="twitter"></amp-social-share> <amp-social-share class="amp-social-share btn-whatsapp" width="auto" height="35" type="whatsapp" data-share-endpoint="whatsapp://send" data-param-text="https://www.unotv.com/noticias/portal/nacional/detalle/hay-dos-medicamentos-que-podrian-atacar-al-covid-19-salud-944523/"></amp-social-share> <amp-social-share class="amp-social-share btn-email" width="auto" height="35" type="email" data-param-subject="Mira esta noticia en UnoTV.com"></amp-social-share> </div> <div class="panel-content"> <div class="panel-principal-media"><amp-img width="750" height="450" layout="responsive" src="/portal/unotv/imagenes/217658-Principal.jpg" alt="Actualmente se cuenta con dos medicamentos que podr&iacute;an tratar el nuevo coronavirus Covid-19. Foto: Cuartoscuro. "> <amp-img src="/assets/img/image-placeholder.png" fallback width="750" height="450" layout="responsive" alt="Uno TV"></amp-img> </amp-img> </div><div class="panel-image-meta"><p><i class="fas fa-camera"></i>Actualmente se cuenta con dos medicamentos que podr&iacute;an tratar el nuevo coronavirus Covid-19. Foto: Cuartoscuro. </p></div> <div class="panel-article"> <p dir="ltr">De acuerdo con Gustavo Reyes Ter&#225;n, titular de la <strong>Comisi&#243;n Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad</strong>, actualmente se cuenta con <strong>dos medicamentos</strong> que podr&#237;an ser potenciales para <strong>tratar </strong>el nuevo <strong>coronavirus Covid-19.</strong></p><div class="banner"><amp-ad width="300" height="600" layout="fixed" type="doubleclick" data-slot="/121173452/UnoTV/noticias/nacional/MB08" data-multi-size="300x250" data-multi-size-validation="false" rtc-config='{"urls":["https://cdn.krxd.net/userdata/v2/amp/68975038-df03-48c2-b339-e58be1b85a15?segments_key=ksg&kuid_key=kuid", "https://ads.us.e-planning.net/hb/1/1d821/ADCID/HB_AMP/ROS?dc=1&e=ATTR(width)xATTR(height)!ATTR(data-slot)&ur=HREF"],"vendors":{"prebidappnexus":{"PLACEMENT_ID":"17112521"}},"timeoutMillis":750}'></amp-ad></div> <p dir="ltr">Se trata de un medicamento que <strong>actualmente es utilizado para el paludismo o malaria</strong> llamado <strong>hidroxicloroquina</strong> y otro que ha sido utilizado para el <strong>coronavirus SARS</strong> denominado <strong>remdesivir</strong>, los cuales <strong>podr&#237;an tratar el Covid-19.</strong>&nbsp;</p> <p dir="ltr">Reyes Ter&#225;n se&#241;al&#243; que, si bien <strong>hasta ahora no existen tratamientos para el nuevo coronavirus</strong>, estos dos medicamentos podr&#237;an ser potenciales, especialmente el remdesivir.&nbsp;</p> <p dir="ltr"><em><strong>Probablemente remdesivir es el que mayor potencial puede tener, sin embargo, para saber si un medicamento funciona, aunque haya demostrado tener actividad contra los virus, es necesario hacer ensayos cl&#237;nicos&#8221;, indic&#243;.</strong></em></p><div class="banner"><amp-ad width=300 height=1 type="teads" data-pid="95522" layout="responsive"> </amp-ad></div> <p dir="ltr">En tanto que la <strong>hidroxicloroquina</strong>, propuesta por un <strong>investigador</strong> del <strong>Instituto Nacional de Enfermedades Respiratorias</strong> (INER), actualmente se encuentra en <strong>evaluaci&#243;n</strong> por parte de los comit&#233;s de &#233;tica para <strong>avalar su potencial en pacientes hospitalizados.</strong></p> <p dir="ltr">Por ello, el funcionario detall&#243; que ya se <strong>preparan dos ensayos cl&#237;nicos</strong>, para que, en el caso de que se llegue a tener&nbsp;<strong>pacientes hospitalizados</strong> en el pa&#237;s, a causa de esta enfermedad, se prueben en ellos.</p> <p dir="ltr"><em><strong>M&#233;xico ser&#237;a un pa&#237;s m&#225;s de los que en conjunto obtendr&#237;an una muestra suficientemente representativa para decir si realmente funciona o no funciona el medicamento&#8221;, agreg&#243;.</strong></em></p> <p dir="ltr">Por otro lado, indic&#243; que un grupo de <strong>investigadores</strong> de la <strong>Universidad Nacional Aut&#243;noma de M&#233;xico</strong> (UNAM) y de los <strong>institutos nacionales de Enfermedades Respiratorias</strong> y de <strong>Ciencias M&#233;dicas Salvador Zubir&#225;n </strong>lograron secuenciar el <strong>genoma </strong>del <strong>primer caso de Covid-19</strong> que <strong>lleg&#243; a M&#233;xico.</strong></p> <p dir="ltr">Una vez secuenciados m&#225;s genomas se podr&#225; conocer <strong>c&#243;mo afecta a la salud de las personas</strong>, de acuerdo con las caracter&#237;sticas gen&#233;ricas de la poblaci&#243;n.</p> <h3>Te recomendamos</h3><div class="panel-related"><a class="internacional item" href="https://www.unotv.com/noticias/portal/internacional/detalle/china-utiliza-medicamento-cubano-cura-coronavirus-337054//"><div class="thumb"><amp-img src="/portal/unotv/imagenes/214919-Principal.jpg" layout="responsive" width="750" height="450"><amp-img src="/assets/img/image-placeholder.png" fallback width="750" height="450" layout="responsive" alt="Uno TV"></amp-img></amp-img></div><div class="item-content"><h2>China utiliza medicamento cubano para tratar coronavirus</h2></div></a><a class="nacional item" href="https://www.unotv.com/noticias/portal/nacional/detalle/coronavirus-tendra-vacuna-al-menos-dentro-anio-medio-unam-963666//"><div class="thumb"><amp-img src="/portal/unotv/imagenes/217628-Principal.jpg" layout="responsive" width="750" height="450"><amp-img src="/assets/img/image-placeholder.png" fallback width="750" height="450" layout="responsive" alt="Uno TV"></amp-img></amp-img></div><div class="item-content"><h2>Coronavirus tendr&aacute; vacuna al menos dentro de a&ntilde;o y medio: UNAM</h2></div></a><a class="internacional item" href="https://www.unotv.com/noticias/portal/internacional/detalle/union-europea-eleva-de-moderado-a-alto-nivel-de-riesgo-por-covid-19-177393//"><div class="thumb"><amp-img src="/portal/unotv/imagenes/217537-Principal.jpg" layout="responsive" width="750" height="450"><amp-img src="/assets/img/image-placeholder.png" fallback width="750" height="450" layout="responsive" alt="Uno TV"></amp-img></amp-img></div><div class="item-content"><h2>Uni&oacute;n Europea eleva de moderado a alto, nivel de riesgo por COVID-19</h2></div></a></div> <div class="panel-denuncia"> <h3>&iexcl;Denuncia en Uno!</h3> <p>&iquest;Conoces o tienes <strong>fotos y videos </strong>de alg&uacute;n acto de posible negligencia, corrupci&oacute;n y abuso de autoridad? M&aacute;ndalo al <strong>WhatsApp de Uno TV: 5562115131. </strong>&iexcl;Comp&aacute;rtelo! Nosotros le damos seguimiento.</p> </div> <div class="banner"> <amp-ad rtc-config='{"urls":["https://cdn.krxd.net/userdata/v2/amp/68975038-df03-48c2-b339-e58be1b85a15?segments_key=ksg&kuid_key=kuid", "https://ads.us.e-planning.net/hb/1/1d821/ADCID/HB_AMP/ROS?dc=1&e=ATTR(width)xATTR(height)!ATTR(data-slot)&ur=HREF"],"vendors":{"prebidappnexus":{"PLACEMENT_ID":"17112617"}},"timeoutMillis":750}' width="300" height="600" layout="fixed" type="doubleclick" data-slot="/121173452/UnoTV/noticias/nacional/MB01"></amp-ad> </div> <h3>&iquest;Qu&eacute; opinas?</h3> <amp-facebook-comments width="486" height="300" layout="responsive" data-numposts="5" data-locale="es_LA" data-href="https://www.unotv.com/noticias/portal/nacional/detalle/hay-dos-medicamentos-que-podrian-atacar-al-covid-19-salud-944523/"></amp-facebook-comments> <amp-embed width="100" height="100" type="taboola" layout="responsive" heights="(min-width:1508px) 295%, (min-width:1018px) 308%, (min-width:699px) 327%, (min-width:475px) 356%, 398%" data-publisher="cmi-unotv" data-mode="thumbnails-b-amp" data-placement="below content" data-target_type="mix" data-article="auto" data-url=""></amp-embed> </div> </div> </article> </section> </div> </main> <amp-sticky-ad layout="nodisplay"> <amp-ad rtc-config='{"urls":["https://cdn.krxd.net/userdata/v2/amp/68975038-df03-48c2-b339-e58be1b85a15?segments_key=ksg&kuid_key=kuid", "https://ads.us.e-planning.net/hb/1/1d821/ADCID/HB_AMP/ROS?dc=1&e=ATTR(width)xATTR(height)!ATTR(data-slot)&ur=HREF"],"vendors":{"prebidappnexus":{"PLACEMENT_ID":"17112446"}},"timeoutMillis":750}' width="320" height="50" layout="fixed" type="doubleclick" data-slot="/121173452/UnoTV/noticias/nacional/AB01"> </amp-ad> </amp-sticky-ad> <footer role="contentinfo"> <div class="container"> <div class="panel-copyright"> <p>Derechos Reservados &copy; <span>2020</span></p> <p>AMX Contenido S.A. de C.V.</p> </div> <div class="panel-follow-social"> <ul> <li class="facebook"><a href="https://www.facebook.com/UnoTVNoticias" rel="me" target="_blank" title="Síguenos en Facebook" aria-label="Síguenos en Facebook"><i class="fab fa-facebook-f"></i></a></li> <li class="twitter"><a href="https://twitter.com/UnoNoticias" rel="me" target="_blank" title="Síguenos en Twitter" aria-label="Síguenos en Twitter"><i class="fab fa-twitter"></i></a></li> <li class="youtube"><a href="https://www.youtube.com/UnoTV" rel="me" target="_blank" title="Suscríbete en Youtube" aria-label="Suscríbete en Youtube"><i class="fab fa-youtube"></i></a></li> <li class="instagram"><a href="https://www.instagram.com/unotv_" rel="me" target="_blank" title="Síguenos en Instagram" aria-label="Síguenos en Instagram"><i class="fab fa-instagram"></i></a></li> </ul> </div> </div> <div class="container"> <div class="panel-logo"><a href="/" aria-label="UnoTV.com"> <amp-img src="/assets/img/logo-unotv-alt.svg" width="140" height="40" layout="fixed" alt="UnoTV.com"></amp-img></a></div> <div class="panel-legales"> <ul> <li><a href="/acerca-de/terminos-de-uso/">T&eacute;rminos de Uso</a></li> <li><a href="/acerca-de/politicas-de-privacidad/">Aviso de Privacidad</a></li> <li><a href="/acerca-de/responsable-derecho-de-replica/">Responsable de derecho de r&eacute;plica</a></li> </ul> </div> </div> </footer> </body> </html>
